Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 5/20 | 0.59 |
| ▸ | CPT2 | P23786 | 1/20 | 0.59 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17656832 | 1.00 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL31629798 | 1.00 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL4416232 | 1.00 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL9550997 | 0.77 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL29074266 | 0.77 | ACLY (0.54) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2190166 | 0.76 | ACLY (0.64) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17181757 | 0.74 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2111332 | 0.74 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17181773 | 0.74 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL6773065 | 0.74 | ACLY (1.00) | ACLYCPT2HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115177727-A | Linked gene inactivation biomarkers and targets for cancer therapy | 得克萨斯系统大学董事会 | 2022-10-14 | — | — | CN | claimed |
| EP-3727361-A1 | TREATMENT OF PAIN AND/OR PAIN RELATED SYMPTOMS ASSOCIATED WITH DYSMENORRHEA | Alyra Biotech Pty Ltd (AU) | 2020-10-28 | — | — | EP | claimed |
| US-20170216459-A1 | COMPOSTIONS AND METHODS FOR DIAGNOSIS OF AXIAL PAIN WITH OR WITHOUT RADICULOPATHY | WARSAW ORTHOPEDIC INC (US) | 2017-08-03 | — | — | US | claimed |
| US-9452182-B2 | Collateral gene inactivation biomarkers and targets for cancer therapy | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-09-27 | — | — | US | claimed |
| US-20150104439-A1 | PHARMACEUTICAL REMOVAL OF NEURONAL EXTENSIONS FROM A DEGENERATING DISC | WARSAW ORTHOPEDIC INC (US) | 2015-04-16 | — | — | US | claimed |
| US-20140378529-A1 | COLLATERAL GENE INACTIVATION BIOMARKERS AND TARGETS FOR CANCER THERAPY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2014-12-25 | — | — | US | claimed |
| EP-2790738-A2 | COLLATERAL GENE INACTIVATION BIOMARKERS AND TARGETS FOR CANCER THERAPY | The Board of Regents of The University of Texas System (US) | 2014-10-22 | — | — | EP | claimed |
| EP-2632552-A1 | INHIBITION OF MICROBIAL GROWTH BY ACONITASE INHIBITION | The Procter and Gamble Company (US) | 2013-09-04 | — | — | EP | claimed |
| WO-2013090732-A2 | COLLATERAL GENE INACTIVATION BIOMARKERS AND TARGETS FOR CANCER THERAPY | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-06-20 | — | — | WO | claimed |
| US-20130108610-A1 | Inhibition of Microbial Growth by Aconitase Inhibition | THE PROCTER & GAMBLE COMPANY | 2013-05-02 | — | — | US | claimed |
| US-20070287991-A1 | Devices and methods for detection of markers of axial pain with or without radiculopathy | MEDTRONIC, INC. | 2007-12-13 | — | — | US | claimed |
| US-20070253928-A1 | Pharmaceutical removal of neuronal extensions from a degenerating disc | WARSAW ORTHOPEDIC, INC. | 2007-11-01 | — | — | US | claimed |
| US-20070253930-A1 | Pharmaceutical removal of vascular and/or neuronal extensions form a degenerating disc | WARSAW ORTHOPEDIC, INC. | 2007-11-01 | — | — | US | claimed |
| EP-1789030-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | claimed |
| EP-1789107-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | claimed |
| WO-2006024488-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | claimed |
| WO-2006024492-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | claimed |
| WO-2004028448-A9 | METHOD OF ALLEVIATING PAIN VIA INHIBITION OF NEUROTRANSMITTER SYNTHESIS | MILLER KENNETH E (US) | 2004-12-02 | — | — | WO | claimed |
| US-20040126368-A1 | Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLOHOMA | 2004-07-01 | — | — | US | claimed |
| WO-2004028448-A2 | METHOD OF ALLEVIATING PAIN VIA INHIBITION OF NEUROTRANSMITTER SYNTHESIS | MILLER KENNETH E (US) | 2004-04-08 | — | — | WO | claimed |